Literature DB >> 26039966

Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG.

Alyssa Cairns1, Richard Bogan1,2,3.   

Abstract

STUDY
OBJECTIVES: The objectives of this study were to quantify the (1) sensitivity and specificity of nocturnal PSG SOREMP (REM latency ≤ 15 min) for narcolepsy in those being evaluated for hypersomnolence and (2) prevalence and predictors of SOREMP during baseline PSG for patients being evaluated for various sleep disorders.
DESIGN: This was a retrospective analysis of a large repository of de-identified PSG and MSLT test results from 2007 to 2013. SETTING AND PATIENTS: Patient records were retrieved from a repository of studies completed at a variety of sleep laboratories across the USA. Included in the analyses were 79,651 general sleep clinic patients (without an MSLT; 48% male; 72% Caucasian) and an additional 3,059 patients (31.3% male; 72% Caucasian) being evaluated for hypersomnolence (with a consecutive MSLT).
INTERVENTIONS: NA. MEASUREMENTS AND
RESULTS: For patients being evaluated for hypersomnolence, the prevalence of PSG SOREMP increased in a dose-response fashion with the number of REM onsets that occurred on a consecutive MSLT (0.5% for no MSLT SOREMPs to > 33.0% for those with 5 MSLT SOREMPs). Overall, having a PSG SOREMP was highly specific (99.5%; 95% CI: 99.1-99.7%) but not sensitive (6.7%; 95% CI: 4.7-9.2%) for narcolepsy. The prevalence of PSG SOREMP for patients in the general sleep clinic sample (i.e., not being evaluated by a consecutive MSLT) was 0.8% and was much higher in those that work night/swing shift. In adjusted models, African American race contributed to the most variance in PSG SOREMP.
CONCLUSIONS: A short onset rapid eye movement (REM) latency occurs rarely in general sleep clinic samples (< 1.0%), but is highly specific for the diagnosis of narcolepsy. Although rare, the prevalence of the phenomenon is much higher than the estimated prevalence of narcolepsy and may provide a critical opportunity for practitioners to identify narcolepsy in sleep clinic patients. These data also suggest that the utility of polysomnography (PSG) short onset REM peroid (SOREMP) for the diagnosis of narcolepsy may be altered by a history of shift/night work and/ or other factors that may allow for a rebound of REM sleep (e.g., undergoing a positive airway pressure titration), supporting published guidelines that other sleep disorders and insufficient and/or poorly timed sleep should be ruled out and/or adequately controlled for prior to conducting sleep testing. Further research is needed to understand racial differences in PSG SOREMP and narcolepsy. This study was limited in that data on cataplexy (with exception to that in final diagnosis) and habitual sleep duration were not available.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  MSLT; PSG; REM; SOREMP; narcolepsy

Mesh:

Year:  2015        PMID: 26039966      PMCID: PMC4576331          DOI: 10.5665/sleep.5050

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  26 in total

Review 1.  Disrupted nighttime sleep in narcolepsy.

Authors:  Thomas Roth; Yves Dauvilliers; Emmanuel Mignot; Jacques Montplaisir; Josh Paul; Todd Swick; Phyllis Zee
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

2.  Performance of an automated polysomnography scoring system versus computer-assisted manual scoring.

Authors:  Atul Malhotra; Magdy Younes; Samuel T Kuna; Ruth Benca; Clete A Kushida; James Walsh; Alexandra Hanlon; Bethany Staley; Allan I Pack; Grace W Pien
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

5.  A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy.

Authors:  Luca Vignatelli; Giuseppe Plazzi; Francesco Peschechera; Laureta Delaj; Roberto D'Alessandro
Journal:  Sleep Med       Date:  2010-09-17       Impact factor: 3.492

6.  Clinical aspects of narcolepsy-cataplexy across ethnic groups.

Authors:  Michele L Okun; Ling Lin; Zerrin Pelin; Sungchul Hong; Emmanuel Mignot
Journal:  Sleep       Date:  2002-02-01       Impact factor: 5.849

7.  Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people.

Authors:  Thomas D Koepsell; William T Longstreth; Thanh G N Ton
Journal:  J Sleep Res       Date:  2009-08-31       Impact factor: 3.981

8.  Prevalence of narcolepsy in King County, Washington, USA.

Authors:  W T Longstreth; Thanh G N Ton; Thomas Koepsell; Vivian H Gersuk; Audrey Hendrickson; Sarah Velde
Journal:  Sleep Med       Date:  2008-11-13       Impact factor: 3.492

9.  Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.

Authors:  Aviv Goldbart; Paul Peppard; Laurel Finn; Chad M Ruoff; Jodi Barnet; Terry Young; Emmanuel Mignot
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

10.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Authors:  Olivier Andlauer; Hyatt Moore; Laura Jouhier; Christopher Drake; Paul E Peppard; Fang Han; Seung-Chul Hong; Francesca Poli; Giuseppe Plazzi; Ruth O'Hara; Emmanuel Haffen; Thomas Roth; Terry Young; Emmanuel Mignot
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

View more
  3 in total

Review 1.  Genetic Ancestry for Sleep Research: Leveraging Health Inequalities to Identify Causal Genetic Variants.

Authors:  Bharati Prasad; Richa Saxena; Namni Goel; Sanjay R Patel
Journal:  Chest       Date:  2018-03-28       Impact factor: 9.410

2.  The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.

Authors:  Chad Ruoff; Fabio Pizza; Lynn Marie Trotti; Karel Sonka; Stefano Vandi; Joseph Cheung; Swaroop Pinto; Mali Einen; Narong Simakajornboon; Fang Han; Paul Peppard; Sona Nevsimalova; Giuseppe Plazzi; David Rye; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

3.  Diagnosing narcolepsy in the active duty military population.

Authors:  Bernadette Villarreal; Tyler Powell; Matthew S Brock; Shana Hansen
Journal:  Sleep Breath       Date:  2021-02-25       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.